Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.36 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | THRB | P10828 | 1/20 | 0.34 |
| ▸ | FNTA | P49354 | 1/20 | 0.34 |
| ▸ | FNTB | P49356 | 1/20 | 0.34 |
| ▸ | PGGT1B | P53609 | 1/20 | 0.34 |
| ▸ | GRIK1 | P39086 | 2/20 | 0.33 |
| ▸ | GRIA4 | P48058 | 1/20 | 0.33 |
| ▸ | GRIK3 | Q13003 | 1/20 | 0.33 |
| ▸ | GRIK5 | Q16478 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1127391 | 1.00 | TDP1 (0.36) | TDP1FFAR3ALDH1A1THRBFNTA | |
| Dimethylamine SCHEMBL10973447 | 0.78 | FFAR3 (0.44) | TDP1FFAR3ALDH1A1THRBFNTA | |
| SCHEMBL6265353 | 0.78 | ALDH1A1 (0.35) | TDP1FFAR3ALDH1A1THRBFNTA | |
| SCHEMBL5143664 | 0.78 | FFAR3 (0.35) | TDP1FFAR3ALDH1A1THRBFNTA | |
| SCHEMBL14600824 | 0.78 | TDP1 (0.35) | TDP1ALDH1A1 | |
| SCHEMBL27684567 | 0.78 | FFAR3 (0.50) | TDP1FFAR3ALDH1A1THRBFNTA | |
| SCHEMBL2139834 | 0.78 | FFAR3 (0.50) | TDP1FFAR3ALDH1A1THRBFNTA | |
| SCHEMBL2094656 | 0.77 | FFAR3 (0.45) | TDP1FFAR3ALDH1A1THRBFNTA | |
| SCHEMBL14094993 | 0.75 | FFAR3 (0.36) | TDP1FFAR3ALDH1A1THRBFNTA | |
| SCHEMBL1509771 | 0.75 | EPHX1 (0.34) | TDP1FFAR3ALDH1A1THRBFNTA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9669243-B2 | Delivery of hydrophobic benefit agents from bodywashes and the like onto a keratinous substrate | BASF SE (DE) | 2017-06-06 | — | — | US | disclosed |
| WO-2012024652-A3 | SYSTEM AND METHODS FOR IMPROVED EFFICIENCY COMPRESSION IGNITION INTERNAL COMBUSTION ENGINE CONTROL | TULA TECHNOLOGY, INC. (US) | 2012-05-10 | — | — | WO | disclosed |
| EP-2282716-A2 | DELIVERY OF HYDROPHOBIC BENEFIT AGENTS FROM BODYWASHES AND THE LIKE ONTO A KERATINOUS SUBSTRATE | BASF SE (DE) | 2011-02-16 | — | — | EP | disclosed |
| US-20100135936-A1 | Delivery of hydrophobic benefit agents from bodywashes and the like onto a keratinous substrate | BASF SE (DE) | 2010-06-03 | — | — | US | disclosed |
| EP-2152230-A2 | SUNSCREEN COMPOSTIONS COMPRISING A RANDOM TERPOLYMER | BASF SE (DE) | 2010-02-17 | — | — | EP | disclosed |
| EP-2129363-A2 | SUNSCREEN AND PERSONAL CARE COMPOSITIONS COMPRISING A SELECT COPOLYMER | BASF SE (DE) | 2009-12-09 | — | — | EP | disclosed |
| WO-2009130144-A2 | DELIVERY OF HYDROPHOBIC BENEFIT AGENTS FROM BODYWASHES AND THE LIKE ONTO A KERATINOUS SUBSTRATE | BASF SE (DE) | 2009-10-29 | — | — | WO | disclosed |
| WO-2008122516-A2 | SUNSCREEN AND PERSONAL CARE COMPOSITIONS COMPRISING A SELECT COPOLYMER | BASF SE (CH) | 2008-10-16 | — | — | WO | disclosed |
| WO-2008122517-A2 | SUNSCREEN COMPOSITIONS COMPRISING A RANDOM TERPOLYMER | BASF SE (CH) | 2008-10-16 | — | — | WO | disclosed |
| US-20080247975-A1 | Sunscreen and personal care compositions comprising a select copolymer | CIBA CORP. | 2008-10-09 | — | — | US | disclosed |
| EP-0893119-B1 | UV-protection formulation | CIBA SC HOLDING AG (CH) | 2003-09-03 | — | — | EP | disclosed |
| EP-1089706-B1 | SUN SCREEN FORMULATIONS | CIBA SC HOLDING AG (CH) | 2003-05-02 | — | — | EP | disclosed |
| US-6521217-B1 | Pulverizating cosmetic carriers and ultraviolet radiation absorbers comprising triazines, amides, benzotriazoles or benzimidazoles, in water in oil or an oil-in-water emulsions to form protective coatings or suntan lotions | CIBA SPECIALTY CHEMICALS CORPORATION | 2003-02-18 | — | — | US | disclosed |
| EP-1187598-A1 | MICROPIGMENT MIXTURE | Ciba SC Holding AG (CH) | 2002-03-20 | — | — | EP | disclosed |
| US-6235271-B1 | A SUNSCREEN AGENT COMPRISING A MICRONIZED ORGANIC ULTRAVIOLET ABSORBER, AN OIL SOLUBLE, NON-MICRONIZED ULTRAVIOLET ABSORBER AND/OR INORGANIC MICROPIGMENT AND A COPOLYMER OF ACRYLIC ACID-STYRENE AS HOLLOW SPHERE | CIBA SPECIALTY CHEMICALS CORPORATION | 2001-05-22 | — | — | US | disclosed |
| EP-1089706-A1 | SUN SCREEN FORMULATIONS | Ciba SC Holding AG (CH) | 2001-04-11 | — | — | EP | disclosed |
| EP-1068866-A2 | Use of mixtures of micropigments for prevening tannig and to induce skin and hair lightening | Ciba SC Holding AG (CH) | 2001-01-17 | — | — | EP | disclosed |
| WO-2000078277-A1 | MICROPIGMENT MIXTURE | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2000-12-28 | — | — | WO | disclosed |
| WO-1999066896-A1 | SUN SCREEN FORMULATIONS | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 1999-12-29 | — | — | WO | disclosed |
| EP-0893119-A1 | UV-protection formulation | Ciba SC Holding AG (CH) | 1999-01-27 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080247975-A1 | Sunscreen and personal care compositions comprising a select copolymer | MSH6, CUTA, ERCC5 | TDP1 982/4885FFAR3 3869/4885ALDH1A1 1329/4885 |
| US-20100135936-A1 | Delivery of hydrophobic benefit agents from bodywashes and the like onto a keratinous substrate | KRT18, ABHD16A, CUTA | TDP1 3698/4885FFAR3 931/4885ALDH1A1 2300/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.